SRI 31215, a small molecule that acts as a triplex inhibitor of matriptase, hepsin and HGFA and mimics the activity of HAI-1/2, endogenous inhibitors of HGF activation with IC50s of 0.69 μM, 0.65 μM, 0.3 μM.
사양
동의어
SRI 31215
사양 및 순도
≥98%
생화학 및 생리적 메커니즘
SRI 31215 (TFA) is a triplex inhibitor of matriptase, hepsin and hepatocyte growth factor activator (HGFA) with IC50 of 0.69 μM, 0.65 μM, 0.3 μM, respectively. SRI 31215 blocks pro-HGF activation and thus mimics the activity of HAI-1/2.
Products are supplied to verified businesses, institutions, and qualified professionals for research and development use only. Not for use in humans, animals, diagnosis, or therapy.